Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iovance Biotherapeutics (IOVA) Non-Current Deffered Revenue (2017 - 2018)

Historic Non-Current Deffered Revenue for Iovance Biotherapeutics (IOVA) over the last 2 years, with Q4 2018 value amounting to $230000.0.

  • Iovance Biotherapeutics' Non-Current Deffered Revenue fell 2255.89% to $230000.0 in Q4 2018 from the same period last year, while for Dec 2018 it was $230000.0, marking a year-over-year decrease of 2255.89%. This contributed to the annual value of $230000.0 for FY2018, which is 2255.89% down from last year.
  • Iovance Biotherapeutics' Non-Current Deffered Revenue amounted to $230000.0 in Q4 2018, which was down 2255.89% from $297000.0 recorded in Q4 2017.
  • Over the past 5 years, Iovance Biotherapeutics' Non-Current Deffered Revenue peaked at $297000.0 during Q4 2017, and registered a low of $230000.0 during Q4 2018.